• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于黏膜疫苗接种的轮状病毒反向遗传学系统及口服疫苗递送载体

Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination.

作者信息

Wang Jun, Qin Songkang, Li Kuanhao, Yin Xin, Sun Dongbo, Chang Jitao

机构信息

State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin 150069, China.

College of Animal Science and Veterinary Medicine, Heilongjiang Bayi Agricultural University, No. 5 Xinfeng Road, Sartu District, Daqing 163319, China.

出版信息

Microorganisms. 2025 Jul 4;13(7):1579. doi: 10.3390/microorganisms13071579.

DOI:10.3390/microorganisms13071579
PMID:40732089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12297967/
Abstract

Mucosal immunization represents a promising strategy for preventing enteric infections. Rotavirus (RV), a leading gastrointestinal pathogen distinguished by its remarkable stability and segmented double-stranded RNA genome, has been engineered into a versatile oral vaccine vector through advanced reverse genetics systems. The clinical efficacy of live-attenuated RV vaccines highlights their unique capacity to concurrently induce mucosal IgA responses and systemic neutralizing antibodies, positioning them as a multiple action vector for multiple immune protection. In this review, we summarize the RV colonization of the intestine and stimulation of intestinal immunity, as well as recent advancements in RV reverse genetics, and focus on their application in the rational design of a multivalent mucosal vaccine vector targeting enteric pathogens considering the advantages and challenges of RV as a vector. We further propose molecular strategies to overcome genetic instability in recombinant RV vectors, including the codon optimization of heterologous inserts. These insights provide a theoretical foundation for developing next-generation mucosal immunization platforms with enhanced safety, stability, and cross-protective efficacy.

摘要

黏膜免疫是预防肠道感染的一种有前景的策略。轮状病毒(RV)是一种主要的胃肠道病原体,以其显著的稳定性和分段双链RNA基因组为特征,通过先进的反向遗传学系统已被改造成为一种通用的口服疫苗载体。减毒活RV疫苗的临床疗效突出了它们同时诱导黏膜IgA反应和全身中和抗体的独特能力,使其成为具有多种免疫保护作用的多效性载体。在本综述中,我们总结了RV在肠道中的定植及对肠道免疫的刺激,以及RV反向遗传学的最新进展,并鉴于RV作为载体的优势和挑战,着重探讨其在合理设计针对肠道病原体的多价黏膜疫苗载体中的应用。我们进一步提出克服重组RV载体遗传不稳定性的分子策略,包括对异源插入片段进行密码子优化。这些见解为开发具有更高安全性、稳定性和交叉保护效力的下一代黏膜免疫平台提供了理论基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/aa38208af84f/microorganisms-13-01579-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/c08b24fef45f/microorganisms-13-01579-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/b2f38f7cf49e/microorganisms-13-01579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/f84464b3d3c0/microorganisms-13-01579-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/d616f214ac79/microorganisms-13-01579-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/536c8ee3e4ea/microorganisms-13-01579-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/aa38208af84f/microorganisms-13-01579-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/c08b24fef45f/microorganisms-13-01579-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/b2f38f7cf49e/microorganisms-13-01579-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/f84464b3d3c0/microorganisms-13-01579-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/d616f214ac79/microorganisms-13-01579-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/536c8ee3e4ea/microorganisms-13-01579-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2fb1/12297967/aa38208af84f/microorganisms-13-01579-g006.jpg

相似文献

1
Rotavirus Reverse Genetics Systems and Oral Vaccine Delivery Vectors for Mucosal Vaccination.用于黏膜疫苗接种的轮状病毒反向遗传学系统及口服疫苗递送载体
Microorganisms. 2025 Jul 4;13(7):1579. doi: 10.3390/microorganisms13071579.
2
Mucosal Delivery of Recombinant Vesicular Stomatitis Virus Vectors Expressing Envelope Proteins of Respiratory Syncytial Virus Induces Protective Immunity in Cotton Rats.黏膜途径传递表达呼吸道合胞病毒包膜蛋白的重组水疱性口炎病毒载体诱导棉鼠产生保护性免疫。
J Virol. 2021 Feb 24;95(6). doi: 10.1128/JVI.02345-20.
3
Development of a recombinant Lactobacillus casei strain expressing Bovine rotavirus VP4 and VP7 proteins as an oral vaccine candidate against calf enteritis.表达牛轮状病毒VP4和VP7蛋白的重组干酪乳杆菌菌株作为预防犊牛肠炎口服疫苗候选株的研制。
Vet Ital. 2026 May 26;61(3). doi: 10.12834/VetIt.3740.34491.2.
4
A rotavirus VP4 or VP7 monoreassortant panel identifies genotypes that are less susceptible to neutralization by systemic antibodies induced by vaccination or natural infection.一组轮状病毒VP4或VP7单重配病毒株可鉴定出对疫苗接种或自然感染诱导产生的全身抗体中和作用敏感性较低的基因型。
mBio. 2025 Jul 9;16(7):e0089725. doi: 10.1128/mbio.00897-25. Epub 2025 May 30.
5
Nanoparticle based oral delivery of vaccines: A promising solution for immunization challenges in developing nations; A comprehensive review.基于纳米颗粒的口服疫苗递送:发展中国家免疫挑战的一个有前景的解决方案;综述
Int J Pharm. 2025 Aug 20;681:125848. doi: 10.1016/j.ijpharm.2025.125848. Epub 2025 Jun 14.
6
Global, regional, and national trends in routine childhood vaccination coverage from 1980 to 2023 with forecasts to 2030: a systematic analysis for the Global Burden of Disease Study 2023.1980年至2023年全球、区域和国家儿童常规疫苗接种覆盖率趋势及2030年预测:2023年全球疾病负担研究的系统分析
Lancet. 2025 Jun 24. doi: 10.1016/S0140-6736(25)01037-2.
7
Harnessing flagellin of as a surface display scaffold for an HIV-1 epitope.利用[某种细菌]的鞭毛蛋白作为HIV-1表位的表面展示支架。 (注:原文中“of ”部分信息缺失,这里补充了“某种细菌”以便使译文更完整通顺,但实际翻译时需根据准确原文信息调整)
Appl Environ Microbiol. 2025 Jun 18;91(6):e0067425. doi: 10.1128/aem.00674-25. Epub 2025 May 29.
8
Reverse Genetics of Murine Rotavirus: A Comparative Analysis of the Wild-Type and Cell-Culture-Adapted Murine Rotavirus VP4 in Replication and Virulence in Neonatal Mice.鼠轮状病毒的反向遗传学:野生型和细胞适应型鼠轮状病毒 VP4 在复制和新生小鼠毒力方面的比较分析。
Viruses. 2024 May 12;16(5):767. doi: 10.3390/v16050767.
9
Recombinant BCG-Based HIV Vaccine: Failures and Promising Approaches for a Successful Vaccine Strategy.基于重组卡介苗的HIV疫苗:成功疫苗策略的失败与前景方法
Vaccines (Basel). 2025 Jun 3;13(6):606. doi: 10.3390/vaccines13060606.
10
Management of urinary stones by experts in stone disease (ESD 2025).结石病专家对尿路结石的管理(2025年结石病专家共识)
Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085.

本文引用的文献

1
Innate immune sensing of rotavirus by intestinal epithelial cells leads to diarrhea.肠道上皮细胞对轮状病毒的天然免疫感应会导致腹泻。
Cell Host Microbe. 2025 Mar 12;33(3):408-419.e8. doi: 10.1016/j.chom.2025.02.005. Epub 2025 Mar 3.
2
Insights into recent advancements in human and animal rotavirus vaccines: Exploring new frontiers.人类和动物轮状病毒疫苗的最新进展洞察:探索新领域
Virol Sin. 2025 Feb;40(1):1-14. doi: 10.1016/j.virs.2024.12.001. Epub 2024 Dec 11.
3
Efficient and robust reverse genetics system for bovine rotavirus generation and its application for antiviral screening.
用于牛轮状病毒产生的高效且稳健的反向遗传学系统及其在抗病毒筛选中的应用。
Virol Sin. 2024 Dec;39(6):917-928. doi: 10.1016/j.virs.2024.09.010. Epub 2024 Sep 29.
4
Generation of single-round infectious rotavirus with a mutation in the intermediate capsid protein VP6.产生单个轮次感染性轮状病毒,其中中间衣壳蛋白 VP6 发生突变。
J Virol. 2024 Jul 23;98(7):e0076224. doi: 10.1128/jvi.00762-24. Epub 2024 Jun 5.
5
A Mini-Review on the Common Antiviral Drug Targets of Coronavirus.冠状病毒常见抗病毒药物靶点的小型综述
Microorganisms. 2024 Mar 17;12(3):600. doi: 10.3390/microorganisms12030600.
6
Changes in vaccine coverage and incidence of acute gastroenteritis and severe rotavirus gastroenteritis in children <5 years in Shibata City, Niigata Prefecture, Japan.日本新潟县柴田市 5 岁以下儿童疫苗接种率和急性肠胃炎及严重轮状病毒肠胃炎发病率的变化。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2322202. doi: 10.1080/21645515.2024.2322202. Epub 2024 Mar 13.
7
[Expert consensus on immunoprophylaxis of childhood rotavirus gastroenteritis (2024 version)].《儿童轮状病毒胃肠炎免疫预防专家共识(2024年版)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2024 Feb 23;58:1-33. doi: 10.3760/cma.j.cn112150-20231220-00472.
8
Development of recombinant rotavirus carrying herpes simplex virus 2 glycoprotein D gene based on reverse genetics technology.基于反向遗传学技术的携带单纯疱疹病毒 2 糖蛋白 D 基因的重组轮状病毒的研制。
Microbiol Immunol. 2024 Feb;68(2):56-64. doi: 10.1111/1348-0421.13107. Epub 2023 Dec 14.
9
Recovery of Recombinant Rotaviruses by Reverse Genetics.通过反向遗传学技术拯救重组轮状病毒
Methods Mol Biol. 2024;2733:249-263. doi: 10.1007/978-1-0716-3533-9_15.
10
Recombinant rotavirus expressing the glycosylated S1 protein of SARS-CoV-2.表达 SARS-CoV-2 糖基化 S1 蛋白的重组轮状病毒。
J Gen Virol. 2023 Oct;104(10). doi: 10.1099/jgv.0.001899.